Normalization of immune activation in lymphoid tissue following highly active antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 25, Issue 2, 2000, Pages 150-156

  Behbahani, Homira ^a   Landay, Alan ^b   Patterson, Bruce K ^c   Jones, Paul ^b   Pottage, John ^b   Agnoli, Michelle ^b   Andersson, Jan ^a   Spetz, Anna Lena ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b RUSH MEDICAL COLLEGE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cytokines; HAART; HIV; Lymphoid tissue; Pathogenesis; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; CD1 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; MEMBRANE ANTIGEN; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ASSAY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE ANALYSIS; IMMUNE SYSTEM; IMMUNOSTIMULATION; LYMPHOID TISSUE; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE; TONSIL; TONSIL CELL; VIRUS LOAD;

EID: 0034298521     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200010010-00009     Document Type: Article

References (33)

1. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
2. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection
3. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less
4. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
5. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy
6. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure
7. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy
8. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study
9. + T-cell repertoire that are not immediately restored by antiviral or immune-based therapies
10. + T cell repopulation of lymphoid tissues after treatment of HIV-1 infection
11. + T cell homeostasis and function in advanced HIV disease
12. + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1
13. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
14. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy
15. +) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues
16. + T cells using a combination of cytokines
17. Detection of HIV-1 DNA in cells and tissue by fluorescent in situ 5'-nuclease assay (FISNA)
18. Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract
19. Targeted suppression of cytokine production in monocytes but not in T lymphocytes by a tetravalent guanylhydrazone (CNI-1493)
20. Concomitant in vivo production of 19 different cytokines in human tonsils
21. Detection and quantification of cytokine-producing cells by immunostaining
22. Computerized assessment of production of multiple human cytokines at the single-cell level using image analysis
23. Dendritic cells and the control of immunity
24. The macrophage origin of the HIV-expressing multinucleated giant cells in hyperplastic tonsils and adenoids
25. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
26. Quantitative image analysis of HIV-1 infection in lymphoid tissue
27. Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection
28. Incidence of discontinuation of highly active antiretroviral combination therapy (HAART) and its determinants
29. From TCR engagement to T cell activation: A kinetic view of T cell behavior
30. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
31. Repertoire of chemokine receptor expression in the female genital tract: Implications for human immunodeficiency virus transmission
32. Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response
33. Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team